Bimzelx 160 mg, solution injectable en seringue préremplie

7680685480019 CH-68548 Lösung
Bimzelx 160 mg, solution injectable en seringue préremplie
Bimzelx 160 mg, solution injectable en seringue préremplie
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/10/2025
Patient information leaflet
Français
04/10/2025
Patient information leaflet
Italien
04/10/2025
Summary of Product Characteristics
Allemand
04/10/2025
Summary of Product Characteristics
Français
04/10/2025
Summary of Product Characteristics
Italien
04/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.45 MG Substance HBESI

Reimbursement information

Public price
CHF 1058.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2024

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
68548
Drug name
Bimzelx, solution injectable en seringue préremplie
Galenic form
INLFS
ATC Code
L04AC21
Authorization status
Z
Dispensing category
B
First authorization
27/10/2022
Authorization expiration date
26/10/2027
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
BIMZELX 160 mg/ml ser pré (emb individ) 1 ml
Description (DE)
BIMZELX 160 mg/ml Fertspr (Einzelpackung) 1 ml
Market launch
27/10/2022
Narcotic (BTM)
No

Other package sizes (2)

BIMZELX 160 mg/ml ser pré (emb double) 2 x 1 ml
2 FESP
GTIN: 7680685480026
View
None
1 FESP
GTIN: None
Not in V1